EXO
IT Services and IT ConsultingArgentina201-500 Employees
Somos una empresa pionera en la fabricación de productos tecnológicos en Argentina desde 1978, brindando soluciones integrales a nuestros clientes.
Innovative Technology Focus eXoZymes is pioneering AI-enhanced enzyme solutions for biomanufacturing, opening opportunities to sell advanced biotech tools, platforms, and related software to support their growth and R&D efforts.
Investment and Partnership Opportunities With active participation in major investor conferences and leadership visibility, there is potential to engage with eXoZymes for strategic funding, collaborations, or joint ventures in sustainable biotech and environmentally friendly processes.
Market Expansion Potential As a company gaining media attention and expanding its scientific leadership, eXoZymes could be interested in solutions that accelerate commercial scaling, manufacturing efficiency, and global market penetration for bio-based products.
Sustainability and Biotech Growth Their focus on transforming sustainable feedstock into nutraceuticals and medicines presents sales opportunities in ESG-focused industries, including bio-materials, green chemistry, and eco-friendly supply chains.
Research and Development Enhancements Leaders joining technical committees indicate a need for research tools, scientific equipment, and data management systems, making R&D support services an attractive sales avenue for cutting-edge biotech innovation.
EXO uses 8 technology products and services including Cloudflare, WhatsApp Business, Ruby, and more. Explore EXO's tech stack below.
| EXO Email Formats | Percentage |
| FirstL@exo.com.ar | 79% |
| LastF@exo.com.ar | 10% |
| FLast@exo.com.ar | 6% |
| FirstLast@exo.com.ar | 5% |
IT Services and IT ConsultingArgentina201-500 Employees
Somos una empresa pionera en la fabricación de productos tecnológicos en Argentina desde 1978, brindando soluciones integrales a nuestros clientes.
EXO's revenue is estimated to be in the range of $25M$50M
EXO's revenue is estimated to be in the range of $25M$50M